Phase 1CompletedINTERVENTIONAL
Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood
ClinicalTrials.gov · NCT02650206 · Registry updated: 2020-06-09
- Condition / research focus
- Diabetes Mellitus, Type 2; Diabetes Mellitus, Type II; Diabetes Mellitus, Adult-Onset; Inflammation
- Sponsor
- Stanford University
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2015-01. Completion: 2019-09-27 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Victoza (liraglutide) with dietician monitoring (drug) — also listed as: liraglutide
- Placebo with dietician monitoring (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Freidenrich Center for Translational Research (FCTR)
Stanford, California, United States
Site recruitment: Not reported